Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytomegalovirus | 12 | 2019 | 40 | 2.820 |
Why?
|
| Pericytes | 4 | 2019 | 22 | 2.150 |
Why?
|
| Cytomegalovirus Infections | 5 | 2019 | 23 | 1.750 |
Why?
|
| Herpesvirus 8, Human | 9 | 2011 | 25 | 1.420 |
Why?
|
| Kidney Glomerulus | 3 | 2019 | 84 | 1.350 |
Why?
|
| Sarcoma, Kaposi | 5 | 2011 | 20 | 1.210 |
Why?
|
| Kidney Diseases | 2 | 2019 | 167 | 1.150 |
Why?
|
| Vaginosis, Bacterial | 2 | 2016 | 6 | 0.960 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 186 | 0.960 |
Why?
|
| Cytokines | 6 | 2019 | 602 | 0.890 |
Why?
|
| Virus Replication | 5 | 2019 | 278 | 0.860 |
Why?
|
| Mesangial Cells | 2 | 2019 | 9 | 0.770 |
Why?
|
| Podocytes | 2 | 2018 | 35 | 0.740 |
Why?
|
| Placenta | 2 | 2019 | 97 | 0.730 |
Why?
|
| BK Virus | 1 | 2019 | 5 | 0.690 |
Why?
|
| Polyomavirus Infections | 1 | 2019 | 21 | 0.680 |
Why?
|
| Trophoblasts | 2 | 2020 | 24 | 0.650 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 18 | 0.630 |
Why?
|
| Postoperative Complications | 1 | 2019 | 210 | 0.620 |
Why?
|
| Chorionic Villi | 1 | 2017 | 4 | 0.610 |
Why?
|
| Blood-Retinal Barrier | 1 | 2017 | 8 | 0.590 |
Why?
|
| Brain | 3 | 2015 | 1346 | 0.580 |
Why?
|
| Eye Diseases | 1 | 2017 | 24 | 0.580 |
Why?
|
| Retina | 2 | 2019 | 280 | 0.550 |
Why?
|
| Genome, Viral | 6 | 2009 | 109 | 0.540 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 159 | 0.540 |
Why?
|
| Cells, Cultured | 8 | 2017 | 1518 | 0.540 |
Why?
|
| Fibroblasts | 1 | 2017 | 272 | 0.530 |
Why?
|
| Blood-Brain Barrier | 2 | 2013 | 162 | 0.470 |
Why?
|
| Humans | 31 | 2023 | 37093 | 0.440 |
Why?
|
| Up-Regulation | 2 | 2012 | 513 | 0.420 |
Why?
|
| Gardnerella vaginalis | 1 | 2011 | 1 | 0.410 |
Why?
|
| Vagina | 1 | 2011 | 81 | 0.400 |
Why?
|
| Down-Regulation | 2 | 2011 | 435 | 0.390 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 76 | 0.380 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 67 | 0.380 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 123 | 0.380 |
Why?
|
| HIV-1 | 2 | 2016 | 706 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 172 | 0.360 |
Why?
|
| Galectin 3 | 1 | 2009 | 26 | 0.360 |
Why?
|
| Multigene Family | 1 | 2009 | 106 | 0.340 |
Why?
|
| Epithelial Cells | 1 | 2011 | 384 | 0.320 |
Why?
|
| Kidney Transplantation | 3 | 2019 | 86 | 0.320 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 189 | 0.300 |
Why?
|
| Phylogeny | 3 | 2009 | 644 | 0.290 |
Why?
|
| Endothelium, Vascular | 3 | 2019 | 237 | 0.270 |
Why?
|
| Pregnancy | 4 | 2020 | 1549 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 807 | 0.250 |
Why?
|
| Endothelial Cells | 3 | 2013 | 308 | 0.240 |
Why?
|
| Fibronectins | 2 | 2015 | 66 | 0.220 |
Why?
|
| Antigens, Viral | 3 | 2009 | 43 | 0.210 |
Why?
|
| Molecular Sequence Data | 13 | 2009 | 1568 | 0.210 |
Why?
|
| Melanoma | 1 | 2023 | 96 | 0.210 |
Why?
|
| Animals | 12 | 2019 | 15081 | 0.200 |
Why?
|
| HIV Infections | 1 | 2016 | 2303 | 0.200 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 893 | 0.200 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2020 | 7 | 0.190 |
Why?
|
| Decidua | 1 | 2020 | 8 | 0.190 |
Why?
|
| Amnion | 1 | 2020 | 16 | 0.190 |
Why?
|
| Streptococcus | 1 | 2020 | 16 | 0.190 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2015 | 110 | 0.190 |
Why?
|
| Stromal Cells | 1 | 2020 | 49 | 0.190 |
Why?
|
| Streptococcal Infections | 1 | 2020 | 34 | 0.180 |
Why?
|
| Female | 9 | 2023 | 20969 | 0.180 |
Why?
|
| Immediate-Early Proteins | 4 | 2002 | 46 | 0.180 |
Why?
|
| Virus Activation | 1 | 2019 | 35 | 0.170 |
Why?
|
| Amino Acid Sequence | 10 | 2009 | 1180 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 97 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 623 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2018 | 7 | 0.160 |
Why?
|
| Chemokine CCL5 | 1 | 2018 | 39 | 0.160 |
Why?
|
| Vero Cells | 2 | 2017 | 93 | 0.160 |
Why?
|
| Viral Proteins | 6 | 2003 | 174 | 0.150 |
Why?
|
| Open Reading Frames | 5 | 2007 | 77 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2017 | 101 | 0.150 |
Why?
|
| Genes, Viral | 6 | 2009 | 63 | 0.150 |
Why?
|
| Macrophages | 1 | 2020 | 439 | 0.140 |
Why?
|
| Neurons | 2 | 2015 | 1175 | 0.140 |
Why?
|
| Sequence Alignment | 4 | 2009 | 265 | 0.140 |
Why?
|
| Causality | 1 | 2016 | 44 | 0.140 |
Why?
|
| Nocardia asteroides | 1 | 1995 | 1 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2019 | 753 | 0.130 |
Why?
|
| Inflammation | 1 | 2020 | 618 | 0.130 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 90 | 0.130 |
Why?
|
| Macaca mulatta | 4 | 1996 | 128 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 1995 | 155 | 0.130 |
Why?
|
| Vimentin | 1 | 2015 | 37 | 0.130 |
Why?
|
| Antigens | 1 | 2015 | 56 | 0.130 |
Why?
|
| Proteoglycans | 1 | 2015 | 47 | 0.120 |
Why?
|
| Visual Pathways | 1 | 2015 | 38 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 75 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2002 | 515 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2231 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 208 | 0.120 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 18 | 0.120 |
Why?
|
| Neuroglia | 1 | 2015 | 124 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 515 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 127 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 307 | 0.120 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 33 | 0.110 |
Why?
|
| Virulence | 2 | 2011 | 223 | 0.110 |
Why?
|
| Base Sequence | 8 | 2002 | 997 | 0.110 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 3 | 0.100 |
Why?
|
| Receptors, Chemokine | 2 | 2002 | 70 | 0.100 |
Why?
|
| Tropoelastin | 1 | 2011 | 13 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1207 | 0.100 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 52 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 146 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 218 | 0.100 |
Why?
|
| Astrocytes | 1 | 2013 | 255 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 245 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2007 | 387 | 0.090 |
Why?
|
| Risk Factors | 1 | 2019 | 3562 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2002 | 174 | 0.090 |
Why?
|
| Microcirculation | 1 | 2009 | 37 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2009 | 502 | 0.090 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 67 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2009 | 24 | 0.090 |
Why?
|
| Cell Line | 4 | 2009 | 1354 | 0.090 |
Why?
|
| Viral Load | 1 | 2011 | 312 | 0.090 |
Why?
|
| Chemokines, CXC | 1 | 2009 | 35 | 0.090 |
Why?
|
| Primates | 1 | 2009 | 36 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 3 | 2003 | 474 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 86 | 0.080 |
Why?
|
| Hela Cells | 1 | 2009 | 366 | 0.080 |
Why?
|
| DNA, Viral | 6 | 1999 | 304 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 268 | 0.080 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 191 | 0.070 |
Why?
|
| Herpesviridae Infections | 2 | 2007 | 18 | 0.060 |
Why?
|
| United States | 3 | 2023 | 4223 | 0.060 |
Why?
|
| SEER Program | 1 | 2023 | 91 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2003 | 21 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 21 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 34 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 174 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 441 | 0.050 |
Why?
|
| Adult | 1 | 2017 | 11712 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2001 | 41 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2007 | 448 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2020 | 65 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 51 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 90 | 0.040 |
Why?
|
| DNA Replication | 1 | 2001 | 152 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2020 | 212 | 0.040 |
Why?
|
| Simian immunodeficiency virus | 2 | 1990 | 59 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 325 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2001 | 148 | 0.040 |
Why?
|
| Elephants | 1 | 1999 | 2 | 0.040 |
Why?
|
| Herpesviridae | 1 | 1999 | 13 | 0.040 |
Why?
|
| Animals, Zoo | 1 | 1999 | 13 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 1990 | 172 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 93 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 213 | 0.040 |
Why?
|
| Species Specificity | 2 | 1997 | 245 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 82 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 356 | 0.040 |
Why?
|
| Alleles | 1 | 1999 | 321 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 90 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2020 | 339 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 539 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2026 | 0.040 |
Why?
|
| Genotype | 3 | 2007 | 730 | 0.040 |
Why?
|
| Paraquat | 1 | 1995 | 21 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2001 | 681 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1995 | 59 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1999 | 517 | 0.030 |
Why?
|
| Herbicides | 1 | 1995 | 44 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 90 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1995 | 859 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 1993 | 57 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 1908 | 0.020 |
Why?
|
| HIV | 1 | 1990 | 98 | 0.020 |
Why?
|
| Male | 3 | 2023 | 20025 | 0.020 |
Why?
|
| Africa | 2 | 1999 | 76 | 0.020 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 41 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 188 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 269 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 578 | 0.020 |
Why?
|
| RNA, Viral | 2 | 2002 | 301 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 41 | 0.010 |
Why?
|
| Virus Latency | 1 | 2002 | 42 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2002 | 72 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 143 | 0.010 |
Why?
|
| Penicillium | 1 | 2001 | 5 | 0.010 |
Why?
|
| Viral Core Proteins | 1 | 2001 | 10 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 211 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 140 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 1999 | 2 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 381 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 523 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 894 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1999 | 6 | 0.010 |
Why?
|
| Taiwan | 1 | 1999 | 14 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1999 | 4 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1999 | 23 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 1999 | 29 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 194 | 0.010 |
Why?
|
| Asia | 1 | 1999 | 75 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 366 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1999 | 45 | 0.010 |
Why?
|
| Thymidylate Synthase | 1 | 1998 | 3 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1998 | 9 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1997 | 8 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 28 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1998 | 153 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 246 | 0.010 |
Why?
|
| Introns | 1 | 1996 | 75 | 0.010 |
Why?
|
| Exons | 1 | 1996 | 88 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 262 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 133 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 651 | 0.010 |
Why?
|
| Superinfection | 1 | 1990 | 2 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 31 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1990 | 20 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 1990 | 35 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1990 | 116 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 1990 | 53 | 0.010 |
Why?
|
| Mice | 1 | 1990 | 5913 | 0.000 |
Why?
|